Dec 17, 2020· Comment from American Academy of Pediatrics· FDA-2020-N-2242-0381
Please accept these comments on behalf of the American Academy of Pediatrics for Docket No. FDA-2020-N-2242 for the December 17 meeting of the FDA's Vaccines and Related Biological Products Advisory Committee to discuss the Moderna, Inc.,COVID-19 Vaccine for the prevention of COVID-19 in individuals 18 years and older. Please let me know if you have any questions or need further clarification.